Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.
Narcolepsy in midbrain structural lesion.
Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis.
Mediterranean diet adherence and risk of multiple sclerosis: a case-control study.
Biological therapy and neurological manifestations. What do we know?
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
Major histocompatibility complex haplotype RT1av1 is associated with relapsing/remitting experimental autoimmune encephalomyelitis.
Abnormal Glycogen Storage by Retinal Neurons in Diabetes.
Effects of different exercise modalities on ataxia in multiple sclerosis patients: a randomized controlled study.
Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis.
Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.
Severe drug-induced liver injury related to therapy with dimethyl fumarate.
Segmenting and Validating Brain Tissue Definitions in the Presence of Varying Tissue Contrast.
Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Control of T cell activation by vitamin D.
Web-based physiotherapy for people moderately affected with Multiple Sclerosis; quantitative and qualitative data from a randomized, controlled pilot study.
Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
Environmental and genetic factors in pediatric inflammatory demyelinating diseases.
Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.
Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study.
Pages
« first
‹ previous
…
731
732
733
734
735
736
737
738
739
…
next ›
last »